BAVARIAN NORDIC
Bavarian Nordic is a industrial biotechnology company developing and producing novel vaccines for the treatment and prevention of life-threatening diseases with a large unmet medical need. The company's business strategy is focused in three areas: biodefence, cancer and infectious diseases.
BAVARIAN NORDIC
Industry:
Biotechnology Health Care Medical
Founded:
1994-01-01
Address:
Kvistgaard, Hovedstaden, Denmark
Country:
Denmark
Website Url:
http://www.bavarian-nordic.com
Total Employee:
251+
Status:
Active
Contact:
(453) 326-8383
Email Addresses:
[email protected]
Total Funding:
328.76 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Domain Not Resolving SSL By Default Google Tag Manager Euro Google Analytics HSTS Google Maps
Similar Organizations
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
Asklepios BioPharmaceutical
Asklepios BioPharmaceutical is a biotechnology company developing adeno-associated virus (AAV) gene therapies for genetic disorders.
CEL-SCI
CEL-SCI is a biotechnology company developing immunotherapy products for the treatment of cancer and other infectious diseases.
Illumina
Illumina is an innovative technology and revolutionary assays aiming the analyze genetic variation and function.
Lineage Cell Therapeutics
Lineage Cell Therapeutics is a clinical-stage biotechnology company developing novel cellular therapies to treat unmet medical needs.
Novatreat
Novatreat is a biotechnology firm, specializes in developing and producing novel immune milk products for the treatment.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Vital Therapies
Vital Therapies is a biotech company focused on developing a cell-based therapy targeting the treatment of acute liver failure.
Current Advisors List
Current Employees Featured
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2023-02-15 | Emergent BioSolutions - Travel Health Business | Emergent BioSolutions - Travel Health Business acquired by Bavarian Nordic | 274 M USD |
| 2009-11-11 | BN ImmunoTherapeutics | BN ImmunoTherapeutics acquired by Bavarian Nordic | N/A |
Investors List
European Investment Bank
European Investment Bank investment in Post-IPO Debt - Bavarian Nordic
National Institutes of Health
National Institutes of Health investment in Grant - Bavarian Nordic
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2016-11-26 | Nabobil.no | Bavarian Nordic investment in Corporate Round - Nabobil.no | 5 M NOK |
Key Employee Changes
| Date | New article |
|---|---|
| 2022-01-19 | Bavarian Nordic Appoints Russell Thirsk as new Chief Operating Officer |
Official Site Inspections
http://www.bavarian-nordic.com Semrush global rank: 1.66 M Semrush visits lastest month: 13.97 K
- Host name: web1.scannet.dk
- IP address: 46.36.210.3
- Location: Randers Denmark
- Latitude: 56.4893
- Longitude: 10.262
- Timezone: Europe/Copenhagen
- Postal: 8900
More informations about "Bavarian Nordic"
Bavarian Nordic - Wikipedia
Bavarian Nordic A/S is a fully integrated biotechnology company focused on the development, manufacturing and commercialization of vaccines. The company is headquartered in Hellerup, Denmark, with manufacturing facilities in Kvistgård, Denmark and Thörishaus [de] near Bern, Switzerland. The company has research and development facilities in Martinsried, Germany and San Diego, C…See details»
Home | USA | Bavarian Nordic
Bavarian nordic Bavarian Nordic is a global vaccines company on a mission to help improve and protect lives through innovative vaccines. With 30 years of excellence in vaccine development and manufacturing, our purpose is driven …See details»
Bavarian Nordic - LinkedIn
Bavarian Nordic | 68,511 followers on LinkedIn. For us, it is all about improving and saving lives. Improving and saving lives through innovative vaccines is at the heart of what we do in …See details»
Bavarian Nordic - Crunchbase Company Profile
Bavarian Nordic is a industrial biotechnology company developing and producing novel vaccines for the treatment and prevention of life-threatening diseases …See details»
Our work in infectious disease vaccines - Bavarian Nordic
To protect the citizens of the US, Canada and Europe, Bavarian Nordic produces a smallpox vaccine for secure national stockpiles. We provided 28 million doses of our vaccine to the US for emergency use in counter bioterrorism efforts. ...See details»
Bavarian Nordic A/S | Reuters
May 9, 2025 Danish biotech Bavarian Nordic said on Thursday it is in discussions with a consortium of Nordic Capital and Permira regarding a potential takeover offer from the two private equity groups ...See details»
Bavarian Nordic
Jul 24, 2025 Bavarian Nordic Announces Closing of Sale of Priority Review Voucher and Upgrades its 2025 Financial Guidance. July 28, 2025. Consortium Led by Nordic Capital and Permira Will Make All-Cash Recommended …See details»
USA - About Bavarian Nordic
As The World Moves Faster, So Should We . Climate change, urbanization, and international travel contribute to the risk of infectious diseases globally. 1 At Bavarian Nordic, we are driven …See details»
Management - Bavarian Nordic
Mr. Juuel joined Bavarian Nordic in 2018 from Orexo AB, a specialty pharmaceutical company listed on the Nasdaq Stockholm exchange, where he served as Chief Financial Officer since 2013. Prior to Orexo, Mr. Juuel held …See details»
News - Bavarian Nordic
Jul 22, 2025 Bavarian Nordic Awarded Contract Options from the U.S. Government for Production and Supply of Freeze-dried Smallpox/Mpox Vaccines May 02, 2025 | Press Releases Bavarian Nordic Receives Marketing …See details»
Sustainability - Bavarian Nordic
At Bavarian Nordic, our priority is to expand our reach and impact by delivering life-changing vaccine solutions. As we grow to reach more people, increase production, and protect more …See details»
Privacy Policy for the United States and Canada - bavarian …
Where you are dealing only with Bavarian Nordic Inc., a US organization, that entity will control and be responsible for the collection and processing of your personal data. Your information …See details»
Bavarian Nordic hiring HR Business Partner and Head of People ...
You will join a dedicated global P&O function supporting a rapidly growing business, reporting directly to the Head of People & Organization, as a part of our global matrix team of four HR ...See details»
Nordic Capital, Permira make $3 billion offer for vaccine maker ...
6 days ago July 28 (Reuters) - A consortium led by Nordic Capital and Permira has made an offer of around $3 billion to buy all the shares of Bavarian Nordic (BAVA.CO), opens new tab, …See details»
Bavarian Nordic - LinkedIn
Bavarian Nordic | 69,241 followers on LinkedIn. For us, it is all about improving and saving lives. Improving and saving lives through innovative vaccines is at the heart of what we do in …See details»
Vaccine maker Bavarian Nordic in takeover talks, shares rally
Jul 24, 2025 Danish biotech Bavarian Nordic said on Thursday it is in discussions with a consortium of Nordic Capital and Permira regarding a potential takeover offer from the two …See details»
Bavarian Nordic: Culture - LinkedIn
At Bavarian Nordic, we aspire to save and improve lives by developing innovative vaccines that are designed to unlock the power of the immune system. We have a strong heritage in vaccine ...See details»
Bavarian Nordic agrees to $3B take-private deal
5 days ago The company’s board of directors plans to unanimously recommend the deal to Bavarian Nordic shareholders when they formally receive Nordic Capital and Permira’s bid in …See details»
Bavarian Nordic to go private - The Pharmaletter
5 days ago Bavarian Nordic’s US traded shares edged up 2.2% to $238.20 on the news. Based on a thorough assessment, the board of directors of Bavarian Nordic has concluded that the …See details»
Bavarian Nordic agrees to $2.99B takeover by Permira and Nordic …
6 days ago Bavarian Nordic (BVNKF) (BAVN) Monday said it agreed to a 19 billion Danish kroner ($2.99 billion) takeover from private-equity companies Permira and Nordic Capital.See details»